In this article, we assess histologically validated quantitative parameters on 18F-piflufolastat (18F-DCFPyL) prostate-specific membrane antigen (PSMA) PET and identify thresholds for differentiating ...

The survival rate for the majority of patients with non-muscle invasive bladder cancer (NMIBC) is favorable; however, the rates of recurrence and progression to muscle-invasive bladder cancer are ...

Renal cell carcinoma (RCC) is a prevalent malignancy with a steadily increasing incidence. This study examined the association between clinical and pathological factors and RCC patient survival ...

Andrea Apolo presents a bone metastasis subanalysis from CheckMate-9ER, encompassing roughly 650 patients with metastatic clear cell renal cell carcinoma, around 25% of whom had bone metastases ...

Kenshiro Shiraishi reports 10-year findings from MRI-guided salvage radiotherapy following radical prostatectomy. In a prospective single-arm trial with 40 patients utilizing 3-Tesla multiparametric ...

Andrea Apolo discusses three nectin-4 ADC trials. EV-302's 3.5-year follow-up showed median overall survival of 33.6 months with enfortumab vedotin plus pembrolizumab, and 30% of patients achieved ...

For patients with metastatic hormone-sensitive prostate cancer who achieve deep prostate-specific antigen responses with androgen deprivation therapy plus an androgen receptor pathway inhibitor, ...

Many older adults with cancer have at least one comorbidity. Type II diabetes mellitus (T2DM) is a common comorbidity among patients with prostate cancer (PC) and represents an important consideration ...

Introduction: Cryoablation is an established nephron-sparing option for small renal masses, particularly in patients unsuitable for surgery. However, definitive histopathological assessment ...

The majority of bladder cancers are diagnosed as non-muscle invasive (NMIBC), with 90% over the age of 55. Although the incidence of several malignancies is increasing among younger adults in whom ...

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and ...

This review is timely due to the rapid integration of suction systems, automated irrigation, and intrarenal pressure (IRP) monitoring in flexible ureteroscopy (FURS). These technological advances are ...